Presentation
Murata T, Hanada K, Shibahara H. Claims database analysis of patients with chronic hepatitis C in Japan. 17th ISPOR Annual European Congress, 10th November 2014, Amsterdam, Netherlands.
Kamae I, Ward T, Webster S, Kobayashi M, McEwan P, Kalsekar A, Yuan Y, Inoue S, Tang A, Kumada H. Investigating treatment strategies to optimize clinical outcomes associated with emerging therapies for HCV. APASL, Asian Pacific Association for The Study of the Liver. Brisbane, Australia,2014.
Kamae I, Ward T, Webster S, Kobayashi M, McEwan P, Yuan Y, Kalsekar A, Inoue S, Tang A, Kumada H. Estimating the long-term clinical and economic outcomes of daclatasvir plus asunaprevir in difficult to treat Japanese patients chronically infected with hepatitis C genotype 1b virus. APASL, Asian Pacific Association for The Study of the Liver. Brisbane, Australia.2014.
Sugiyama N, Murata T, Morishima Y, Fukuma Y, Shibasaki Y, Bidad C, Harnett J, Marshall L, Coindreau JL. Cost-effectiveness of biologics for rhumatoid arthritis patients: a real-world analsis of nationwide Japanese claims data. EULAR 2014, 11-14 June 2014, Paris, France.
Shibahara H, Shiroiwa T, Tange C, Nakamura K, Ozono S, Shimozuma K. Reanalysis of cost-effectiveness of abiraterone acetate as seconed line treatment for metasttic castration-resistant prostate cancer in Japan using a Japanese claim data set. 19th ISPOR Annual International Meeting, 2nd June 2014, Montreal, QC, Canada.
Kohno S, Ohno T, Murata T, Tateda K. Risk factors for the development of pneumonia: analysis of Japanese claims data. The 54th Annual meeting of the Japanese respiratory society. Osaka, Japan. April 25-27th ,2014. (in Japanese)
Kobayashi M. The present conditions and problem of claims data study in Japan. Center for Health Economics & QOL Research, Niigata University of Health and Welfare. Niigata, Japan.25th Jan, 2014. (in Japanese)
Ohno T, Inoue S, Watanabe A. Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine for adult pneumococcal disease. The 54th Annual meeting of the Japanese respiratory society. Osaka, Japan. April 25-27th ,2014. (in Japanese)
Kamae I, Kumada H, Kobayashi M, Ward T, Webster S, Yuan Y, Kalsekar A, Inoue S, Tang A, McEwan P. Estimation of the long-term clinical response of the Daclatasvir/Asunaprevir combination therapy in HCV genotype 1b type Japanese patients. The 50th Annual meeting of Japan Society of Hepatology. Tokyo, Japan. 29-30th May, 2014. (in Japanese)
Noto S, Izumi R, Moriwaki K, Igarashi A, Ikeda S, Fukuda T, Shiroiwa T, Kobayashi M, Saito S, Shimozuma K. Comparing the performance of the EQ-5D-5L with the EQ-5D-3L in stroke patients in Japan. ISPOR 16th Annual International Meeting. Dublin, Ireland. 2013.
